Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Trial Comparing Sentinel Node (SN) Policy to Current French Initial Staging Protocols in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence

NCT02598219 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT02598219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02598219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Trial Comparing Sentinel Node (SN) Policy to Current French Initial Staging Protocols in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence
Lead sponsor
Centre Oscar Lambret
Phase
Phase 3
Overall status
Completed
Start date
November 19, 2015
Completion date
August 26, 2026
Enrollment
262 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

endometrioid carcinoma, non endometrioid carcinoma